INST 0603C Chart Review on Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Pancreatic Cancer
Both
Pancreatic Cancer
Trial Information
INST 0603C Chart Review on Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer
Chart Review to describe the clinical outcomes in patients pancreatic cancer treated with
combination of irinotecan, oxaliplatin and cetuximab.
Inclusion Criteria:
Patients with unresectable/metastatic pancreatic cancer treated in the UNM Cancer Research
and Treatment Center.
Exclusion Criteria:
Not specified.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Principal Investigator
Fa-Chyi Lee, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of New Mexico
Authority:
United States: Institutional Review Board
Study ID:
INST 0603C
NCT ID:
NCT00322712
Start Date:
February 2006
Completion Date:
February 2011
Related Keywords:
- Pancreatic Cancer
- Pancreatic Neoplasms
Name | Location |
|---|---|
| University of New Mexico | Albuquerque, New Mexico 87131 |
